Expectations trend
FY2028 · fiscal year ending 2028-03-31 · fmp
Virtuix Holdings Inc (VTIX)
NASDAQInformation TechnologyComputer HardwareSnapshot 2026-11-05
$0.52-4.36%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyComputer HardwareSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for VTIX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage financial obligations effectively | Recent deals with Streeterville Capital improve financial structure. | Intact | Capital structure weakens with rising net debt or financial distress | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-03-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth story, not a demonstrated durable compounder. The multi-year view is in a watch state, and confidence is low after a decline in confidence from medium; management execution is volatile and recent financial performance is weak.
The evidence does not include a valuation measure or a clear account of market expectations, so whether VTIX is cheap, fair, or expensive versus peers cannot be assessed. Recent earnings beats are positive events, but the evidence also shows weak results relative to the industry cohort and a delisting-related notice, leaving the expectations gap unclear.
Near term, consumer orders may support progress: Omni One orders rose 72% year over year, but quarterly revenue fell to $767,300 from $1,032,136. Fiscal 2026 net sales were $4.3 million versus $3.6 million in fiscal 2025, while the latest quarter had an operating loss of $3,901,973; defense progress is not measurable from the supplied financials. A guidance cut on the next call is a key near-term risk, though the stated miss probability is 35% and the risk tier is quiet.
The multi-year thesis hinges on whether Omni One order momentum becomes sustained revenue growth and whether defense programs produce measurable revenue or larger awards. Near-term conditions could improve if the Fed cuts rates or major technology companies stabilize, while a guidance cut would weaken the setup.
Over the next 1 to 3 years, VTIX remains an uncertain, high-risk thesis with early signs of consumer demand but limited evidence of broad financial delivery. The latest positive earnings events do not resolve the weak performance, low confidence, or delisting-related concern. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Virtuix Holdings Inc's published investment case. The stated target is EPS improves to >= -$0.39. |
| Improving |
| EPS remains below -$0.50 by fiscal 2028 |
Diluted EPS: $-0.09 per share FY2026-Q3; GAAP. Published target: EPS improves to >= -$0.39. Target period ends 2028-03-31; this observation covers 2026-Q3. Mar 6, 2026-0.09 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain revenue growth near 18% YoY | A primary condition in Virtuix Holdings Inc's published investment case. The stated target is >=18% YoY revenue growth. | Broken | YoY revenue growth falls below 10% next fiscal year | Revenue growth: -25.66% FY2027-Q1; GAAP. Published target: >=18% YoY revenue growth. Target period is not explicitly aligned with this observation. Aug 21, 2026-25.659022 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Deliver value from M&A activities | A supporting condition in Virtuix Holdings Inc's published investment case. The stated target is M&A activities lead to measurable revenue or cost benefits within 12 months. | Improving | No revenue or cost benefit from M&A within 12 months | M&A targets $10M-$15M annual revenue vs 12-month benefit target News confirms pursuit of defense M&A with $10M-$15M annual revenue targets and 40% gross margin goals. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.40 → $-0.40 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-25 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-26 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-27 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-28 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-29 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-30 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-07-31 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-01 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-02 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-03 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-04 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-05 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-06 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-08 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-09 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-10 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-12 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-13 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-14 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-15 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-16 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-17 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-18 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-19 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-20 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-21 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-22 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-23 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-24 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-25 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-08-26 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-08-27 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-08-28 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-08-29 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-08-30 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-08-31 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-09-01 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-09-02 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-09-03 | $-0.39 | $18,500,000 | 2 / 2 |
| 2026-09-04 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-05 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-06 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-07 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-08 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-09 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-10 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-11 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-12 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-13 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-14 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-15 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-16 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-17 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-18 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-19 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-20 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-21 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-22 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-23 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-24 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-25 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-26 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-27 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-28 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-29 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-09-30 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-01 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-02 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-03 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-04 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-05 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-06 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-07 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-08 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-09 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-10 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-11 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-12 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-13 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-14 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-15 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-16 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-17 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-18 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-19 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-20 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-21 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-22 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-23 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-24 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-25 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-26 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-27 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-28 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-29 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-30 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-10-31 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-11-01 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-11-02 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-11-03 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-11-04 | $-0.40 | $18,500,000 | 2 / 2 |
| 2026-11-05 | $-0.40 | $18,500,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.